• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米材料辅助基因编辑和合成生物学优化肺部疾病治疗

Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases.

机构信息

Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Institute of Translational Medicine, Zhejiang Shuren University, Hangzhou, Zhejiang, 310015, China.

Department of Pharmacy, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325200, China.

出版信息

J Nanobiotechnology. 2024 Jun 18;22(1):343. doi: 10.1186/s12951-024-02627-w.

DOI:10.1186/s12951-024-02627-w
PMID:38890749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11186260/
Abstract

The use of nanomaterials in gene editing and synthetic biology has emerged as a pivotal strategy in the pursuit of refined treatment methodologies for pulmonary disorders. This review discusses the utilization of nanomaterial-assisted gene editing tools and synthetic biology techniques to promote the development of more precise and efficient treatments for pulmonary diseases. First, we briefly outline the characterization of the respiratory system and succinctly describe the principal applications of diverse nanomaterials in lung ailment treatment. Second, we elaborate on gene-editing tools, their configurations, and assorted delivery methods, while delving into the present state of nanomaterial-facilitated gene-editing interventions for a spectrum of pulmonary diseases. Subsequently, we briefly expound on synthetic biology and its deployment in biomedicine, focusing on research advances in the diagnosis and treatment of pulmonary conditions against the backdrop of the coronavirus disease 2019 pandemic. Finally, we summarize the extant lacunae in current research and delineate prospects for advancement in this domain. This holistic approach augments the development of pioneering solutions in lung disease treatment, thereby endowing patients with more efficacious and personalized therapeutic alternatives.

摘要

纳米材料在基因编辑和合成生物学中的应用,已经成为追求肺部疾病精细化治疗方法的关键策略。本综述讨论了利用纳米材料辅助的基因编辑工具和合成生物学技术,以促进更精确和高效的肺部疾病治疗方法的发展。首先,我们简要概述了呼吸系统的特征,并简要描述了各种纳米材料在肺部疾病治疗中的主要应用。其次,我们详细介绍了基因编辑工具、它们的结构和各种传递方法,同时深入研究了纳米材料辅助的基因编辑干预在一系列肺部疾病中的现状。随后,我们简要阐述了合成生物学及其在生物医学中的应用,重点介绍了在 2019 年冠状病毒病大流行背景下,针对肺部疾病的诊断和治疗的研究进展。最后,我们总结了当前研究中的现存空白,并描绘了该领域的发展前景。这种全面的方法增强了在肺部疾病治疗方面开创性解决方案的发展,从而为患者提供更有效和个性化的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/c4e00f39129b/12951_2024_2627_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/c69a9258c78f/12951_2024_2627_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/5060ac621756/12951_2024_2627_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/2613c460eeb6/12951_2024_2627_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/f4e2eb95f742/12951_2024_2627_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/3ef8215bea69/12951_2024_2627_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/e62a209414aa/12951_2024_2627_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/fbe54d15a5d0/12951_2024_2627_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/c4e00f39129b/12951_2024_2627_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/c69a9258c78f/12951_2024_2627_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/5060ac621756/12951_2024_2627_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/2613c460eeb6/12951_2024_2627_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/f4e2eb95f742/12951_2024_2627_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/3ef8215bea69/12951_2024_2627_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/e62a209414aa/12951_2024_2627_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/fbe54d15a5d0/12951_2024_2627_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ef6/11186260/c4e00f39129b/12951_2024_2627_Fig8_HTML.jpg

相似文献

1
Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases.纳米材料辅助基因编辑和合成生物学优化肺部疾病治疗
J Nanobiotechnology. 2024 Jun 18;22(1):343. doi: 10.1186/s12951-024-02627-w.
2
CRISPR/Cas Technology: The Unique Synthetic Biology Genome-Editing Tool Shifting the Paradigm in Viral Diagnostics, Defense, and Therapeutics.CRISPR/Cas 技术:改变病毒诊断、防御和治疗范式的独特合成生物学基因组编辑工具。
Annu Rev Biomed Eng. 2024 Jul;26(1):247-272. doi: 10.1146/annurev-bioeng-081723-013033. Epub 2024 Jun 20.
3
Delivery of genome-editing biomacromolecules for treatment of lung genetic disorders.基因组编辑生物大分子递送来治疗肺部遗传疾病。
Adv Drug Deliv Rev. 2021 Jan;168:196-216. doi: 10.1016/j.addr.2020.05.002. Epub 2020 May 13.
4
CRISPR/Cas9 Genome Editing Tool: A Promising Tool for Therapeutic Applications on Respiratory Diseases.CRISPR/Cas9 基因组编辑工具:呼吸疾病治疗应用的有前途的工具。
Curr Gene Ther. 2020;20(5):333-346. doi: 10.2174/1566523220666201012145731.
5
Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections.CRISPR-Cas 基因组编辑技术在人类病毒感染中的治疗潜力。
Biomed Pharmacother. 2022 Apr;148:112743. doi: 10.1016/j.biopha.2022.112743. Epub 2022 Feb 25.
6
Mammalian synthetic biology in the age of genome editing and personalized medicine.基因组编辑与个性化医疗时代的哺乳动物合成生物学
Curr Opin Chem Biol. 2017 Oct;40:57-64. doi: 10.1016/j.cbpa.2017.06.003. Epub 2017 Jun 16.
7
COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19.COVID-19 一年后:CRISPR-Cas 系统抗击 COVID-19 的回顾。
Int J Biol Sci. 2021 May 13;17(8):2080-2088. doi: 10.7150/ijbs.60655. eCollection 2021.
8
A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology.CRISPR-dCas 工具包用于基因工程和合成生物学。
J Mol Biol. 2019 Jan 4;431(1):34-47. doi: 10.1016/j.jmb.2018.06.037. Epub 2018 Jun 26.
9
The State-of-the-Art of Gene Editing and its Application to Viral Infections and Diseases Including COVID-19.基因编辑技术的最新进展及其在包括 COVID-19 在内的病毒感染和疾病中的应用。
Front Cell Infect Microbiol. 2022 Jun 9;12:869889. doi: 10.3389/fcimb.2022.869889. eCollection 2022.
10
Gene Editing and Genetic Lung Disease. Basic Research Meets Therapeutic Application.基因编辑与遗传性肺病。基础研究与治疗应用
Am J Respir Cell Mol Biol. 2017 Mar;56(3):283-290. doi: 10.1165/rcmb.2016-0301PS.

引用本文的文献

1
Controlling CRISPR-Cas9 genome editing in human cells using a molecular glue degrader.使用分子胶降解剂控制人类细胞中的CRISPR-Cas9基因组编辑。
Mol Ther Nucleic Acids. 2025 Jul 21;36(3):102640. doi: 10.1016/j.omtn.2025.102640. eCollection 2025 Sep 9.
2
Exosome-Based Therapeutics in Dermatology.基于外泌体的皮肤病治疗方法
Biomater Res. 2025 May 9;29:0148. doi: 10.34133/bmr.0148. eCollection 2025.
3
SynBioNanoDesign: pioneering targeted drug delivery with engineered nanomaterials.合成生物学纳米设计:利用工程纳米材料开创靶向药物递送技术。

本文引用的文献

1
Reduction-to-synthesis: the dominant approach to genome-scale synthetic biology.还原合成法:基因组规模合成生物学的主导方法。
Trends Biotechnol. 2024 Aug;42(8):1048-1063. doi: 10.1016/j.tibtech.2024.02.008. Epub 2024 Feb 28.
2
Extracellular Vesicles and Exosomes: Novel Insights and Perspectives on Lung Cancer from Early Detection to Targeted Treatment.细胞外囊泡与外泌体:从肺癌早期检测到靶向治疗的新见解与展望
Biomedicines. 2024 Jan 7;12(1):123. doi: 10.3390/biomedicines12010123.
3
Prime editing: current advances and therapeutic opportunities in human diseases.
J Nanobiotechnology. 2025 Mar 6;23(1):178. doi: 10.1186/s12951-025-03254-9.
4
Toxicity Evaluation of Sulfobetainized Branched Polyethyleneimine via Antibacterial and Biocompatibility Assays.通过抗菌和生物相容性测定对磺基甜菜碱化支化聚乙烯亚胺的毒性评估
Toxics. 2025 Feb 14;13(2):136. doi: 10.3390/toxics13020136.
碱基编辑:人类疾病中的当前进展和治疗机会。
Sci Bull (Beijing). 2023 Dec 30;68(24):3278-3291. doi: 10.1016/j.scib.2023.11.015. Epub 2023 Nov 7.
4
Nanocarriers for gene delivery to the cardiovascular system.用于向心血管系统递送基因的纳米载体。
Biomater Sci. 2023 Dec 5;11(24):7709-7729. doi: 10.1039/d3bm01275a.
5
Solid lipid nanoparticles: a versatile approach for controlled release and targeted drug delivery.固体脂质纳米粒:一种用于控制释放和靶向药物传递的多功能方法。
J Liposome Res. 2024 Jun;34(2):335-348. doi: 10.1080/08982104.2023.2268711. Epub 2023 Oct 15.
6
Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy.利用吸入式纳米颗粒克服肺部屏障,用于呼吸道疾病治疗。
Adv Drug Deliv Rev. 2023 Nov;202:115111. doi: 10.1016/j.addr.2023.115111. Epub 2023 Oct 10.
7
Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery.用于肺部药物递送的壳聚糖基纳米颗粒的研究进展。
Polymers (Basel). 2023 Sep 21;15(18):3849. doi: 10.3390/polym15183849.
8
Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.基于可生物降解聚合物的眼部疾病药物传递系统。
Int J Mol Sci. 2023 Aug 19;24(16):12976. doi: 10.3390/ijms241612976.
9
Emerging non-viral vectors for gene delivery.新兴的非病毒基因传递载体。
J Nanobiotechnology. 2023 Aug 17;21(1):272. doi: 10.1186/s12951-023-02044-5.
10
CRISPR/Cas9-based application for cancer therapy: Challenges and solutions for non-viral delivery.基于 CRISPR/Cas9 的癌症治疗应用:非病毒递送的挑战与解决方案。
J Control Release. 2023 Sep;361:727-749. doi: 10.1016/j.jconrel.2023.08.028. Epub 2023 Aug 22.